The Pharmaceutical Society of Ireland also directed that John Corr should not be eligible to apply to have his name restored to the register of pharmacists for a period of five years.

Mayo-based bio-tech firm Ovagen was trying to raise funds of €28 million for the patenting of a germ-free egg for use in vaccines when they were introduced to a Swiss banking company called Enerbiz. Its chief executive Adrianus Johannes Kees said he would help Ovagen secure a loan.